Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Young

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Invasive Cardiology|January 5, 2006
Thrombosis, inflammation, and our evolving understanding of vascular biology during interventional therapyJohn J Young
Reviews in Cardiovascular Medicine|April 3, 2007
Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systemsJohn J Young
The Journal of Invasive Cardiology|July 9, 2005
Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionJohn J Young
JACC. Cardiovascular Imaging|April 10, 2009
Detection of vulnerable coronary artery plaques: lesion level risk assessment within the coronary arterial tree?John J Young
The Journal of Invasive Cardiology|April 12, 2013
Facilitated PCI for ST segment elevation myocardial infarctionJohn J Young
Development (Cambridge, England)|August 30, 2023
In preprints: of genitalia and six-legged miceJohn J Young
Reviews in Cardiovascular Medicine|April 3, 2007
Clinical challenges in the prevention and treatment of late and very late stent thrombosis. IntroductionJohn J Young, Dean J Kereiakes
Current Biology : CB|November 23, 2021
Developmental biology: A 5'Hoxd-Gli3 balance in tetrapod axial polaritySamantha R Royle, John J Young
Journal of Interventional Cardiology|June 18, 2002
Cost efficacy of platelet glycoprotein IIb/IIIa antagonists in clinical trials and clinical practiceJohn J Young, Dean J Kereiakes
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2012
Targeted gene disruption with engineered zinc-finger nucleases (ZFNs)John J Young, Richard M Harland
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Invasive Cardiology|January 5, 2006
Thrombosis, inflammation, and our evolving understanding of vascular biology during interventional therapyJohn J Young
Reviews in Cardiovascular Medicine|April 3, 2007
Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systemsJohn J Young
The Journal of Invasive Cardiology|July 9, 2005
Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionJohn J Young
JACC. Cardiovascular Imaging|April 10, 2009
Detection of vulnerable coronary artery plaques: lesion level risk assessment within the coronary arterial tree?John J Young
The Journal of Invasive Cardiology|April 12, 2013
Facilitated PCI for ST segment elevation myocardial infarctionJohn J Young
Development (Cambridge, England)|August 30, 2023
In preprints: of genitalia and six-legged miceJohn J Young
Reviews in Cardiovascular Medicine|April 3, 2007
Clinical challenges in the prevention and treatment of late and very late stent thrombosis. IntroductionJohn J Young, Dean J Kereiakes
Current Biology : CB|November 23, 2021
Developmental biology: A 5'Hoxd-Gli3 balance in tetrapod axial polaritySamantha R Royle, John J Young
Journal of Interventional Cardiology|June 18, 2002
Cost efficacy of platelet glycoprotein IIb/IIIa antagonists in clinical trials and clinical practiceJohn J Young, Dean J Kereiakes
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2012
Targeted gene disruption with engineered zinc-finger nucleases (ZFNs)John J Young, Richard M Harland
Pageof 5